Case Study

Negative News Tipping Point for AstraZeneca Telegraphed Share Price Decline

Written by team at Act Analytics On May 19, 2021

AstraZeneca stock (AZN), along with stocks of other pharmaceutical companies producing COVID-19 vaccines, has experienced considerable volatility as the market incorporates emerging news. Along with the issues of vaccine efficacy, production, and distribution, there are complex questions relating to social equity, who bears vaccine costs, and intellectual property. AZN closed at $51.47 on June 12, 2020 and then rapidly rose 18.7% to close at $61.10 on July 17th. The gains in AZN’s share price were concentrated in just a few days, as AZN announced positive news relating to its COVID vaccine.